Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors

Haiyuan Xu,1,2,* Jinge Shen,3,* Jianxing Xiang,4 Haiyan Li,4 Bing Li,4 Tengfei Zhang,4 Lu Zhang,4 Xinru Mao,4 Hong Jian,5 Yongqian Shu11Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, People’s Republic of China; 2Department of Oncology, Kunshan...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Xu H, Shen J, Xiang J, Li H, Li B, Zhang T, Zhang L, Mao X, Jian H, Shu Y
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Dove Medical Press 2019-07-01
Серія:	Cancer Management and Research
Предмети:	receptor tyrosine kinase fusions acquired resistance EGFR tyrosine kinase inhibitors lung cancer
Онлайн доступ:	https://www.dovepress.com/characterization-of-acquired-receptor-tyrosine-kinase-fusions-as-mecha-peer-reviewed-article-CMAR
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Characterization of acquired receptor tyrosine&ndash;kinase fusions as mechanisms of resistance to EGFR tyrosine&ndash;kinase inhibitors

Схожі ресурси

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors